Metformin × adverse events & safety

SynthesisDisease markers2019

Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis.

Long Yao et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedrandomised · 2019

Randomised comparison

Probably lowered adverse events & safety

−11%−17% to −4%

Bigger than 4 in 10 for adverse events & safety

As reported

RR 0.89, 95% CI 0.83–0.96

One number in the abstract

the abstract, start to end

incidence in diabetic patients (RR = 0.89; 95% CI, 0.83-0.96; CONCLUSION:

← favours treatmentfavours comparator →
could be chance
Adverse events & safety
RR 0.890.83–0.96
MetforminAdverse events & safety

Metformin × adverse events & safetyharms?mixed

unlikelylikely
0.27not counted
← favours treatmentfavours comparator →
more certainless certain
1 / 5

34 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30881522